Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-09 Purchase | 2019-12-10 8:04 pm | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 25,000 | $64.16 | $1,604,000 | 190,992 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-13 Option Award | 2023-02-15 4:47 pm | N/A 2033-02-13 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 16,720 | $0 | 16,720 (Direct) | View |
| 2023-02-03 Tax Withholding | 2023-02-07 4:11 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 1,127 | $44.16 | 145,553 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:11 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 3,375 | $0 | 145,553 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:42 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 13,300 | $0 | 13,300 (Direct) | View |
| 2021-10-19 Tax Withholding | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 1,116 | $40.29 | 142,619 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 3,800 | $0 | 142,619 (Direct) | View |
| 2021-06-15 Tax Withholding | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 1,144 | $58.8 | 139,651 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 4,000 | $0 | 139,651 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 4:02 pm | N/A 2031-02-10 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 22,500 | $0 | 22,500 (Direct) | View |
| 2020-04-28 Option Award | 2020-04-30 4:44 pm | N/A 2030-04-28 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 9,450 | $0 | 9,450 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 4:57 pm | N/A 2030-02-12 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-10 8:04 pm | N/A 2024-01-24 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 15,743 | $0 | 190,992 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-10 8:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 3,076 | $28.63 | 190,992 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-10 8:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 5,732 | $38.25 | 190,992 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-10 8:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 6,935 | $1.36 | 190,992 (Direct) | View |